JP5643121B2 - Method for producing aryl (diolato) boranes - Google Patents
Method for producing aryl (diolato) boranes Download PDFInfo
- Publication number
- JP5643121B2 JP5643121B2 JP2011008157A JP2011008157A JP5643121B2 JP 5643121 B2 JP5643121 B2 JP 5643121B2 JP 2011008157 A JP2011008157 A JP 2011008157A JP 2011008157 A JP2011008157 A JP 2011008157A JP 5643121 B2 JP5643121 B2 JP 5643121B2
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- group
- added
- nmr
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 *C(*)(*C(*)(*)O)N=O Chemical compound *C(*)(*C(*)(*)O)N=O 0.000 description 8
- NSUOBKXLMDVHSH-UHFFFAOYSA-N CB(c1ccc(CCCC)cc1)OC(C)(C)C(C)(C)O Chemical compound CB(c1ccc(CCCC)cc1)OC(C)(C)C(C)(C)O NSUOBKXLMDVHSH-UHFFFAOYSA-N 0.000 description 1
- BRGVKVZXDWGJBX-UHFFFAOYSA-N CCCCc(cc1)ccc1Br Chemical compound CCCCc(cc1)ccc1Br BRGVKVZXDWGJBX-UHFFFAOYSA-N 0.000 description 1
- HDNRAPAFJLXKBV-UHFFFAOYSA-N CCc(cc1)ccc1OC Chemical compound CCc(cc1)ccc1OC HDNRAPAFJLXKBV-UHFFFAOYSA-N 0.000 description 1
- JUXFXYQUXNXVAA-UHFFFAOYSA-N Cc(cc1)ccc1OC(F)(F)F Chemical compound Cc(cc1)ccc1OC(F)(F)F JUXFXYQUXNXVAA-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
本発明は、アリール(ジオラート)ボラン類の製造方法に関する。 The present invention relates to a process for producing aryl (diolate) boranes.
アリール(ジオラート)ボラン類は、医農薬や機能性材料の原料となるビアリール類の合成中間体として重要な化合物である(例えば非特許文献1)。通常これらのボラン類の合成法としては、ハロゲン化アリールに金属リチウムやマグネシウムを作用させてアリール金属種に変換した後、求電子性のホウ素化試薬と反応させる方法が一般的である。しかしながら、金属リチウムやマグネシウムに敏感な官能基を有するものには適用できない。 Aryl (diolate) boranes are important compounds as intermediates for the synthesis of biaryls, which are raw materials for medical pesticides and functional materials (for example, Non-Patent Document 1). Usually, as a method for synthesizing these boranes, a method in which metal halide or magnesium is allowed to act on an aryl halide to convert it to an aryl metal species and then reacted with an electrophilic boration reagent. However, it cannot be applied to those having a functional group sensitive to metallic lithium or magnesium.
また近年、アリール(ジオラート)ボラン類の一つである2−アリール−4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン類の合成法として、4,4,4’,4’,5,5,5’,5’−オクタメチル−2,2’−ビ(1,3,2−ジオキサボロラン)(ビス(ピナコラート)ジボロン)とハロゲン化アリールを遷移金属触媒の存在下に反応させる方法が開示されている(非特許文献2および3)。しかしながら、ビス(ピナコラート)ジボロンは、合成原料が非常に高価であり、かつ合成に多段階を必要とするため、工業的スケールでの利用が制限されている。 In recent years, as a synthesis method of 2-aryl-4,4,5,5-tetramethyl-1,3,2-dioxaborolanes, which is one of aryl (diolate) boranes, 4,4,4 ′, 4 ', 5,5,5', 5'-octamethyl-2,2'-bi (1,3,2-dioxaborolane) (bis (pinacolato) diboron) is reacted with an aryl halide in the presence of a transition metal catalyst Methods have been disclosed (Non-Patent Documents 2 and 3). However, bis (pinacolato) diboron is limited in its use on an industrial scale because the synthetic raw material is very expensive and requires a multi-step synthesis.
一方、合成がより容易で安価な2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体を原料とするアリール(ジオラート)ボラン類の製造方法はこれまでに報告がない。 On the other hand, there has been no report on a process for producing aryl (diolate) boranes using 2,2'-bi (1,3,2-benzodioxaborol) derivatives as raw materials that are easier and cheaper to synthesize.
本発明の目的は、アリール(ジオラート)ボラン類の簡便な製造方法を提供することにある。 An object of the present invention is to provide a simple method for producing aryl (diolate) boranes.
本発明者らは上記の課題を解決すべく鋭意検討を重ねた結果、パラジウム触媒および酢酸塩の存在下、2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体とベンゼン誘導体を反応させ、次いでジオール類を反応させることにより、アリール(ジオラート)ボラン類を製造できることを見出した。 As a result of intensive studies to solve the above problems, the present inventors have found that a 2,2′-bi (1,3,2-benzodioxaborol) derivative and benzene in the presence of a palladium catalyst and acetate. It has been found that aryl (diolate) boranes can be produced by reacting derivatives followed by diols.
すなわち本発明は、パラジウム触媒および酢酸塩の存在下、一般式(1) That is, the present invention provides a compound represented by the general formula (1) in the presence of a palladium catalyst and acetate.
以下に本発明をさらに詳細に説明する。はじめに、2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体(1)、ベンゼン誘導体(2)およびジオール類(3)について説明する。 The present invention is described in further detail below. First, the 2,2′-bi (1,3,2-benzodioxaborol) derivative (1), the benzene derivative (2) and the diols (3) will be described.
本反応で用いることのできる2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体(1)としては、市販品さらには既知の方法で製造することができる化合物を例示することができる。具体的には、2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体(1)のR1で表される炭素数1〜4の直鎖または分岐のアルキル基としては、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、sec−ブチル基、tert−ブチル基等が例示できる。R1は、以上のアルキル基または水素原子のいずれでも良いが、原料入手が容易な点、収率が良い点で水素原子またはtert−ブチル基が好ましく、水素原子がさらに好ましい。 Examples of the 2,2′-bi (1,3,2-benzodioxaborol) derivative (1) that can be used in this reaction include commercially available products and compounds that can be produced by known methods. be able to. Specifically, as the linear or branched alkyl group having 1 to 4 carbon atoms represented by R 1 of the 2,2′-bi (1,3,2-benzodioxaborole) derivative (1), , Methyl group, ethyl group, propyl group, isopropyl group, butyl group, sec-butyl group, tert-butyl group and the like. R 1 may be any of the above alkyl groups or hydrogen atoms, but is preferably a hydrogen atom or a tert-butyl group, more preferably a hydrogen atom in terms of easy availability of raw materials and a good yield.
本発明のベンゼン誘導体(2)としては、市販品さらには既知の方法で製造することができる化合物を例示することができる。具体的には、ベンゼン誘導体(2)のR2中の炭素数1〜6のアルキル基は、直鎖状、分岐状のいずれでもよく、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、sec−ブチル基、tert−ブチル基、ペンチル基、ヘキシル基、ネオペンチル基等が例示できる。これらのアルキル基は、フッ素原子、アミノ基または水酸基で置換されていてもよく、具体的には、トリフルオロメチル基、ジフルオロメチル基、フルオロメチル基、2,2,2−トリフルオロエチル基、1,1,1,3,3,3−ヘキサフルオロイソプロピル基、2−アミノエチル基、3−アミノプロピル基、4−アミノブチル基、5−アミノペンチル基、6−アミノヘキシル基、2−ヒドロキシエチル基、3−ヒドロキシプロピル基、4−ヒドロキシブチル基、5−ヒドロキシペンチル基、6−ヒドロキシヘキシル基等を例示することができる。 Examples of the benzene derivative (2) of the present invention include commercially available products and compounds that can be produced by known methods. Specifically, the alkyl group having 1 to 6 carbon atoms in R 2 of the benzene derivative (2) may be linear or branched, and may be a methyl group, an ethyl group, a propyl group, an isopropyl group, or a butyl group. , Sec-butyl group, tert-butyl group, pentyl group, hexyl group, neopentyl group and the like. These alkyl groups may be substituted with a fluorine atom, an amino group or a hydroxyl group, specifically, a trifluoromethyl group, a difluoromethyl group, a fluoromethyl group, a 2,2,2-trifluoroethyl group, 1,1,1,3,3,3-hexafluoroisopropyl group, 2-aminoethyl group, 3-aminopropyl group, 4-aminobutyl group, 5-aminopentyl group, 6-aminohexyl group, 2-hydroxy Examples thereof include an ethyl group, a 3-hydroxypropyl group, a 4-hydroxybutyl group, a 5-hydroxypentyl group, and a 6-hydroxyhexyl group.
R2中の炭素数1〜4のアルコキシ基は、直鎖状、分岐状のいずれでもよく、メトキシ基、エトキシ基、プロポキシ基、イソプロポキシ基、ブトキシ基、sec−ブチルオキシ基、tert−ブチルオキシ基が例示できる。これらのアルコキシ基は、フッ素原子で置換されていてもよく、トリフルオロメトキシ基、2,2,2−トリフルオロエトキシ基、1,1,1,3,3,3−ヘキサフルオロイソプロポキシ基等が例示できる。 The alkoxy group having 1 to 4 carbon atoms in R 2 may be linear or branched, and is a methoxy group, ethoxy group, propoxy group, isopropoxy group, butoxy group, sec-butyloxy group, tert-butyloxy group. Can be illustrated. These alkoxy groups may be substituted with a fluorine atom, such as a trifluoromethoxy group, 2,2,2-trifluoroethoxy group, 1,1,1,3,3,3-hexafluoroisopropoxy group, etc. Can be illustrated.
R2で表される炭素数1〜4のアルキル基で置換されていてもよいフェニルオキシ基としては、フェニルオキシ基、o−トリルオキシ基、m−トリルオキシ基、p−トリルオキシ基、4−エチルフェニルオキシ基、4−プロピルフェニルオキシ基、4−ブチルフェニルオキシ基等が例示できる。 Examples of the phenyloxy group which may be substituted with an alkyl group having 1 to 4 carbon atoms represented by R 2 include a phenyloxy group, an o-tolyloxy group, an m-tolyloxy group, a p-tolyloxy group, and 4-ethylphenyl. Examples thereof include an oxy group, a 4-propylphenyloxy group, and a 4-butylphenyloxy group.
R2で表される(炭素数1〜4のアルキル)カルボニル基は、直鎖状、分岐状のいずれでもよく、アセチル基、プロピオニル基、ブチリル基、イソブチリル基、バレリル基、イソバレリル基、sec−ブチルカルボニル基、ピバロイル基が例示できる。 The (alkyl group having 1 to 4 carbon atoms) carbonyl group represented by R 2 may be linear or branched, and may be an acetyl group, a propionyl group, a butyryl group, an isobutyryl group, a valeryl group, an isovaleryl group, sec- Examples thereof include a butylcarbonyl group and a pivaloyl group.
R2で表される(炭素数1〜4のアルコキシ)カルボニル基は、直鎖状、分岐状のいずれでもよく、メトキシカルボニル基、エトキシカルボニル基、プロポキシカルボニル基、イソプロポキシカルボニル基、ブトキシカルボニル基、イソブトキシカルボニル基、sec−ブトキシカルボニル基、tert−ブトキシカルボニル基が例示できる。 The (carbonyl group having 1 to 4 carbon atoms) carbonyl group represented by R 2 may be linear or branched, and is a methoxycarbonyl group, ethoxycarbonyl group, propoxycarbonyl group, isopropoxycarbonyl group, butoxycarbonyl group. , Isobutoxycarbonyl group, sec-butoxycarbonyl group, and tert-butoxycarbonyl group.
R2で表されるハロゲン原子としては、フッ素原子、塩素原子、臭素原子、ヨウ素原子等が例示できる。 Examples of the halogen atom represented by R 2 include a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom.
R2で表される、炭素数1〜4のアルキル基、炭素数1〜4のアルキル基で置換されていてもよいフェニル基または(炭素数1〜4のアルキル)カルボニル基で1つないし2つ置換されていてもよいアミノ基のアルキル基は、直鎖状、分岐状のいずれでもよい。炭素数1〜4のアルキル基、炭素数1〜4のアルキル基で置換されていてもよいフェニル基または(炭素数1〜4のアルキル)カルボニル基で1つないし2つ置換されていてもよいアミノ基は、具体的には、アミノ基、メチルアミノ基、エチルアミノ基、プロピルアミノ基、イソプロピルアミノ基、ブチルアミノ基、sec−ブチルアミノ基、tert−ブチルアミノ基、ジメチルアミノ基、ジエチルアミノ基、ジプロピルアミノ基、ジブチルアミノ基、エチルメチルアミノ基、メチルプロピルアミノ基、ブチルメチルアミノ基、フェニルアミノ基、ジフェニルアミノ基、ビス(p−トリル)アミノ基、ビス(m−トリル)アミノ基、ビス(o−トリル)アミノ基、ジナフチルアミノ基、ナフチルフェニルアミノ基、メチルフェニルアミノ基、アセチルアミノ基、プロピオニルアミノ基、ブチリルアミノ基、イソブチリルアミノ基、バレリルアミノ基、イソバレリアミノル基、sec−ブチルカルボニルアミノ基、ピバロイルアミノ基等が例示できる。 1 to 2 of an alkyl group having 1 to 4 carbon atoms, a phenyl group optionally substituted with an alkyl group having 1 to 4 carbon atoms or a (alkyl having 1 to 4 carbon atoms) carbonyl group represented by R 2 The alkyl group of the amino group which may be substituted may be either linear or branched. 1 to 2 carbon atoms may be substituted with an alkyl group having 1 to 4 carbon atoms, a phenyl group that may be substituted with an alkyl group with 1 to 4 carbon atoms, or a (alkyl having 1 to 4 carbon atoms) carbonyl group. Specifically, the amino group is an amino group, a methylamino group, an ethylamino group, a propylamino group, an isopropylamino group, a butylamino group, a sec-butylamino group, a tert-butylamino group, a dimethylamino group, or a diethylamino group. , Dipropylamino group, dibutylamino group, ethylmethylamino group, methylpropylamino group, butylmethylamino group, phenylamino group, diphenylamino group, bis (p-tolyl) amino group, bis (m-tolyl) amino group Bis (o-tolyl) amino group, dinaphthylamino group, naphthylphenylamino group, methylphenylamino group Acetylamino group, propionylamino group, butyrylamino group, isobutyrylamino group, valerylamino group, isovalerylamino rear Minoru group, sec- butyl carbonylamino group, pivaloylamino group and the like.
R2で表される、(フッ素原子で置換されていてもよい炭素数1〜4のアルキル)チオ基のアルキル基は、直鎖状、分岐状のいずれでもよい。(フッ素原子で置換されていてもよい炭素数1〜4のアルキル)チオ基は、具体的には、メチルチオ基、エチルチオ基、プロピルチオ基、イソプロピルチオ基、ブチルチオ基、sec−ブチルチオ基、tert−ブチルチオ基、トリフルオロメチルチオ基、2,2,2−トリフルオロエチルチオ基、1,1,3,3,3−ヘキサフルオロイソプロピルチオ基等が例示できる。 The alkyl group of the thio group (alkyl having 1 to 4 carbon atoms which may be substituted with a fluorine atom) represented by R 2 may be either linear or branched. (C1-C4 alkyl optionally substituted with a fluorine atom) The thio group is specifically a methylthio group, ethylthio group, propylthio group, isopropylthio group, butylthio group, sec-butylthio group, tert- Examples include butylthio group, trifluoromethylthio group, 2,2,2-trifluoroethylthio group, 1,1,3,3,3-hexafluoroisopropylthio group.
R2で表される(フッ素原子で置換されていてもよいフェニル)オキシスルホニル基としては、具体的には、フェニルオキシスルホニル基、4−フルオロフェニルオキシスルホニル基、3−フルオロフェニルオキシスルホニル基、2−フルオロフェニルオキシスルホニル基、3,5−ジフルオロフェニルオキシスルホニル基、3,4−ジフルオロフェニルオキシスルホニル基、2,4,6−トリフルオロフェニルオキシスルホニル基、2,3,4,5,6−ペンタフルオロフェニルオキシスルホニル基等が例示できる。 Specific examples of the oxysulfonyl group represented by R 2 (phenyl optionally substituted with a fluorine atom) include a phenyloxysulfonyl group, a 4-fluorophenyloxysulfonyl group, a 3-fluorophenyloxysulfonyl group, 2-fluorophenyloxysulfonyl group, 3,5-difluorophenyloxysulfonyl group, 3,4-difluorophenyloxysulfonyl group, 2,4,6-trifluorophenyloxysulfonyl group, 2,3,4,5,6 -A pentafluorophenyloxysulfonyl group etc. can be illustrated.
またR2が隣接する水酸基である場合、これらが一体となって、炭素数1から3のアルキレンジオキシ基を形成してもよく、具体的には、メチレンジオキシ基、エチレンジオキシ基、プロピレンジオキシ基等を例示することができる。 When R 2 is an adjacent hydroxyl group, these may be combined to form an alkylenedioxy group having 1 to 3 carbon atoms. Specifically, a methylenedioxy group, an ethylenedioxy group, A propylene dioxy group etc. can be illustrated.
ベンゼン誘導体(2)のXは、収率が良い点で臭素原子が好ましい。 X of the benzene derivative (2) is preferably a bromine atom in terms of good yield.
R3、R4およびAの組合せで表されるジオール類(3)としては、1,2−エタンジオール、1,3−プロパンジオール、2,3−ブタンジオール、2,3−ジメチル−2,3−ブタンジオール、カテコール、2,2−ジメチル−1,3−プロパンジオール,2,4−ペンタンジオール、2,4−ジメチル−2,4−ペンタンジオール、2,5−ヘキサンジオール、2,5−ジメチル−2,5−ヘキサンジオール等が例示できる。 Examples of the diols (3) represented by the combination of R 3 , R 4 and A include 1,2-ethanediol, 1,3-propanediol, 2,3-butanediol, 2,3-dimethyl-2, 3-butanediol, catechol, 2,2-dimethyl-1,3-propanediol, 2,4-pentanediol, 2,4-dimethyl-2,4-pentanediol, 2,5-hexanediol, 2,5 -Dimethyl-2,5-hexanediol etc. can be illustrated.
次に本発明の製造方法を説明する。本発明の製造方法は、パラジウム触媒および酢酸塩の存在下、2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体(1)とベンゼン誘導体(2)を反応させる工程1と、次いでジオール類(3)を反応させる工程2からなる。 Next, the manufacturing method of this invention is demonstrated. The production method of the present invention comprises a step 1 of reacting a 2,2′-bi (1,3,2-benzodioxaborol) derivative (1) and a benzene derivative (2) in the presence of a palladium catalyst and an acetate. Then, the step 2 comprises reacting the diols (3).
工程1の反応は、溶媒中で実施することができる。用いることのできる溶媒としては、テトラヒドロフラン、ジエチルエーテル、シクロペンチルメチルエーテル、メチル−tert−ブチルエーテル、1,2−ジメトキシエタン等のエーテル系溶媒、N,N−ジメチルホルムアミド、N−メチルホルムアミド、N−メチルピロリドン、1,3−ジメチル−2−イミダゾリドン等のアミド系溶媒、ジメチルスルホキシド、ジエチルスルホキシド等のスルホキシド系溶媒、メタノール、エタノール、プロパノール、2−プロパノール、エチレングリコール、イソプロピルアルコール、ブタノール、sec−ブチルアルコール、tert−ブチルアルコール、シクロヘキサノール、ヘキサノール、トリフルオロエタノール等のアルコール系溶媒、アセトニトリル、プロピオニトリル等のニトリル系溶媒等の有機溶媒や、水を例示することができる。さらにはこれらの混合溶媒が例示できる。さらに具体的には、ジメチルスルホキシド、N,N−ジメチルホルムアミド、1,2−ジメトキシエタン、エタノール、tert−ブチルアルコール、エタノールとジメチルスルホキシドの混合溶媒、tert−ブチルアルコールとジメチルスルホキシドの混合溶媒、エタノールと水の混合溶媒が好ましい。溶媒の使用量に特に制限は無い。 The reaction of step 1 can be carried out in a solvent. Solvents that can be used include ether solvents such as tetrahydrofuran, diethyl ether, cyclopentyl methyl ether, methyl-tert-butyl ether, 1,2-dimethoxyethane, N, N-dimethylformamide, N-methylformamide, N-methyl. Amido solvents such as pyrrolidone, 1,3-dimethyl-2-imidazolidone, sulfoxide solvents such as dimethyl sulfoxide, diethyl sulfoxide, methanol, ethanol, propanol, 2-propanol, ethylene glycol, isopropyl alcohol, butanol, sec-butyl alcohol , Alcohol solvents such as tert-butyl alcohol, cyclohexanol, hexanol and trifluoroethanol, and nitrile solvents such as acetonitrile and propionitrile. And organic solvents like, can be exemplified water. Furthermore, these mixed solvents can be illustrated. More specifically, dimethyl sulfoxide, N, N-dimethylformamide, 1,2-dimethoxyethane, ethanol, tert-butyl alcohol, a mixed solvent of ethanol and dimethyl sulfoxide, a mixed solvent of tert-butyl alcohol and dimethyl sulfoxide, ethanol A mixed solvent of water and water is preferred. There is no restriction | limiting in particular in the usage-amount of a solvent.
工程1の反応は、パラジウム触媒の存在下に行うことが必須である。用いることができるパラジウム化合物としては、ジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウム、ジクロロビス(トリフェニルホスフィン)パラジウム、テトラキス(トリフェニルホスフィン)パラジウム、ビス(ジフェニルホスフィノメタン)パラジウム、ビス(ジフェニルホスフィノエタン)パラジウム、ビス(ジフェニルホスフィノブタン)パラジウム、ビス(ジフェニルホスフィノプロパン)パラジウム、ビス(ジフェニルホスフィノフェロセン)パラジウム、トリス[トリ(tert−ブチル)ホスフィン]パラジウム、ジクロロビス[トリ(tert−ブチル)ホスフィン)]パラジウム、ジブロモビス[トリ(tert−ブチル)ホスフィン)]パラジウム等のホスフィン配位パラジウム錯体が例示できる。 It is essential to perform the reaction of Step 1 in the presence of a palladium catalyst. Palladium compounds that can be used include dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium, dichlorobis (triphenylphosphine) palladium, tetrakis (triphenylphosphine) palladium, bis (diphenylphosphinomethane) palladium. Bis (diphenylphosphinoethane) palladium, bis (diphenylphosphinobutane) palladium, bis (diphenylphosphinopropane) palladium, bis (diphenylphosphinoferrocene) palladium, tris [tri (tert-butyl) phosphine] palladium, dichlorobis Phosphine coordinated palladium complexes such as [tri (tert-butyl) phosphine)] palladium, dibromobis [tri (tert-butyl) phosphine)] palladium It can be shown.
また、これらのホスフィン配位パラジウム錯体や、ジクロロビス(アセトニトリル)パラジウム、ジクロロビス(ベンゾニトリル)パラジウム、塩化パラジウム、ジクロロ(1,5−シクロオクタジエン)パラジウム、酢酸パラジウム、(π−アリル)クロロパラジウム、ビス(アセチルアセトナート)パラジウム、臭化パラジウム等のパラジウム化合物と、トリフェニルホスフィン、トリメチルホスフィン、トリエチルホスフィン、トリプロピルホスフィン、トリイソプロピルホスフィン、トリブチルホスフィン、トリイソブチルホスフィン、トリ−tert−ブチルホスフィン、トリシクロヘキシルホスフィン、1,2−ビス(2,5−ジエチルホスホラノ)エタン、シクロヘキシルジフェニルホスフィン、メチルジフェニルホスフィン、エチルジフェニルホスフィン、プロピルジフェニルホスフィン、イソプロピルジフェニルホスフィン、ブチルジフェニルホスフィン、イソブチルジフェニルホスフィン、tert−ブチルジフェニルホスフィン、9,9−ジメチル−4,5−ビス(ジフェニルホスフィノ)キサンテン、2−(ジフェニルホスフィノ)−2’−(N,N−ジメチルアミノ)ビフェニル、1,2−ビス(2,5−ジメチルホスホラノ)ベンゼン、1,1’−ビス(ジイソプロピルホスフィノ)フェロセン、1,2−ビス(2,5−ジイソプロピルホスホラノ)ベンゼン、1,2−ビス(2,5−ジイソプロピルホスホラノ)ベンゼン、2−(ジ−tert−ブチルホスフィノ)ビフェニル、2−(ジシクロヘキシルホスフィノ)ビフェニル、2−(ジシクロヘキシルホスフィノ)−2’−メチルビフェニル、ビス(ジフェニルホスフィノ)メタン、1,2−ビス(ジフェニルホスフィノ)エタン、1,3−ビス(ジフェニルホスフィノ)プロパン、1,4−ビス(ジフェニルホスフィノ)ブタン、1,4−ビス(ジフェニルホスフィノ)ペンタン、1,1’−ビス(ジフェニルホスフィノ)フェロセン、cis−1,2−ビス(ジフェニルホスフィノ)エチレン、ビス(2−ジフェニルホスフィノエチル)フェニルホスフィン、1,2−ビス(ジフェニルホスフィノ)プロパン、トリス(3,5−ジメチルフェニル)ホスフィン、トリス(4−メトキシフェニル)ホスフィン、トリス(2,4,6−トリメトキシフェニル)ホスフィン、トリ(m−トリル)ホスフィン、トリ(o−トリル)ホスフィン、トリ(p−トリル)ホスフィン、1,2−ビス(ジフェニルホスフィノ)ベンゼン、2,2’−ビス(ジフェニルホスフィノ)−1,1’−ビフェニル、ビス(2−メトキシフェニル)フェニルホスフィン、1,2−ビス(ジフェニルホスフィノ)ベンゼン、1−[2−(ジフェニルホスフィノ)フェロセニル]エチルジ−tert−ブチルホスフィン、2−ジシクロヘキシルホスフィノ−2’−(N,N−ジメチルアミノ)ビフェニル、トリス(トリメチルシリル)ホスフィン、2−ジ−tert−ブチルホスフィノ−2’−(N,N−ジメチルアミノ)ビフェニル、2−ジ−tert−ブチルホスフィノ−2’−メチルビフェニル、2−(ジシクロヘキシルホスフィノ)ビフェニルおよび2−(ジシクロヘキシルホスフィノ)−2’,4’,6’−トリイソプロピル−1,1’−ビフェニル等の三級ホスフィンを組合せたパラジウム触媒を用いることもできる。ホスフィン配位パラジウム錯体やパラジウム化合物と三級ホスフィンを組み合わせたパラジウム触媒を用いる場合、パラジウムと三級ホスフィンのモル比に特に制限はないが、収率が良い点で0.1〜100が好ましく、0.5〜5がさらに好ましい。 These phosphine coordinated palladium complexes, dichlorobis (acetonitrile) palladium, dichlorobis (benzonitrile) palladium, palladium chloride, dichloro (1,5-cyclooctadiene) palladium, palladium acetate, (π-allyl) chloropalladium, Palladium compounds such as bis (acetylacetonato) palladium and palladium bromide, triphenylphosphine, trimethylphosphine, triethylphosphine, tripropylphosphine, triisopropylphosphine, tributylphosphine, triisobutylphosphine, tri-tert-butylphosphine, tri Cyclohexylphosphine, 1,2-bis (2,5-diethylphosphorano) ethane, cyclohexyldiphenylphosphine, methyldiphenylphosphine Ethyldiphenylphosphine, propyldiphenylphosphine, isopropyldiphenylphosphine, butyldiphenylphosphine, isobutyldiphenylphosphine, tert-butyldiphenylphosphine, 9,9-dimethyl-4,5-bis (diphenylphosphino) xanthene, 2- (diphenylphosphino) ) -2 ′-(N, N-dimethylamino) biphenyl, 1,2-bis (2,5-dimethylphosphorano) benzene, 1,1′-bis (diisopropylphosphino) ferrocene, 1,2-bis ( 2,5-diisopropylphosphorano) benzene, 1,2-bis (2,5-diisopropylphosphorano) benzene, 2- (di-tert-butylphosphino) biphenyl, 2- (dicyclohexylphosphino) biphenyl, 2- (Dicyclohex Silphosphino) -2′-methylbiphenyl, bis (diphenylphosphino) methane, 1,2-bis (diphenylphosphino) ethane, 1,3-bis (diphenylphosphino) propane, 1,4-bis (diphenylphosphino) ) Butane, 1,4-bis (diphenylphosphino) pentane, 1,1′-bis (diphenylphosphino) ferrocene, cis-1,2-bis (diphenylphosphino) ethylene, bis (2-diphenylphosphinoethyl) ) Phenylphosphine, 1,2-bis (diphenylphosphino) propane, tris (3,5-dimethylphenyl) phosphine, tris (4-methoxyphenyl) phosphine, tris (2,4,6-trimethoxyphenyl) phosphine, Tri (m-tolyl) phosphine, tri (o-tolyl) phosphine Tri (p-tolyl) phosphine, 1,2-bis (diphenylphosphino) benzene, 2,2′-bis (diphenylphosphino) -1,1′-biphenyl, bis (2-methoxyphenyl) phenylphosphine, 1 , 2-bis (diphenylphosphino) benzene, 1- [2- (diphenylphosphino) ferrocenyl] ethyldi-tert-butylphosphine, 2-dicyclohexylphosphino-2 ′-(N, N-dimethylamino) biphenyl, tris (Trimethylsilyl) phosphine, 2-di-tert-butylphosphino-2 ′-(N, N-dimethylamino) biphenyl, 2-di-tert-butylphosphino-2′-methylbiphenyl, 2- (dicyclohexylphosphino ) Biphenyl and 2- (dicyclohexylphosphino) -2 ', ', It can be used a palladium catalyst which is a combination of a tertiary phosphine such as 6'-triisopropyl-1,1'-biphenyl. When using a palladium catalyst in which a phosphine coordination palladium complex or a palladium compound and a tertiary phosphine are combined, the molar ratio of palladium and tertiary phosphine is not particularly limited, but is preferably 0.1 to 100 in terms of good yield. 0.5 to 5 is more preferable.
パラジウム触媒としては、収率が良い点や入手容易な点で、ジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウム、ジクロロビス(トリフェニルホスフィン)パラジウム、テトラキス(トリフェニルホスフィン)パラジウムや、ジクロロビス(アセトニトリル)パラジウム、塩化パラジウムまたは酢酸パラジウムとトリフェニルホスフィンを組み合わせたパラジウム触媒が好ましい。 As a palladium catalyst, dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium, dichlorobis (triphenylphosphine) palladium, tetrakis (triphenylphosphine) palladium, Palladium catalyst combining dichlorobis (acetonitrile) palladium, palladium chloride or palladium acetate and triphenylphosphine is preferred.
パラジウム触媒の使用量に特に制限は無く、いわゆる触媒量でも十分反応は進行し、目的物を収率よく得ることができる。 There is no restriction | limiting in particular in the usage-amount of a palladium catalyst, even if it is what is called a catalyst amount, reaction will fully advance and the target object can be obtained with a sufficient yield.
工程1の反応は、酢酸塩の存在下に行うことが必須である。用いることができる酢酸塩としては、酢酸リチウム、酢酸ナトリウム、酢酸カリウム、酢酸セシウム等のアルカリ金属の酢酸塩、酢酸マグネシウム、酢酸カルシウム等のアルカリ土類金属の酢酸塩、酢酸銅、酢酸銀等の1B族金属の酢酸塩等が例示でき、これらの混合物を用いても良い。収率が良い点で、アルカリ金属塩が好ましく、酢酸ナトリウム、酢酸カリウムおよびこれらの混合物がさらに好ましい。 It is essential to carry out the reaction of step 1 in the presence of acetate. Examples of acetates that can be used include alkali metal acetates such as lithium acetate, sodium acetate, potassium acetate, and cesium acetate, alkaline earth metal acetates such as magnesium acetate and calcium acetate, copper acetate, and silver acetate. Examples include 1B group metal acetates, and mixtures thereof may be used. In terms of good yield, alkali metal salts are preferred, and sodium acetate, potassium acetate and mixtures thereof are more preferred.
酢酸塩の使用量に特に制限は無いが、収率が良い点でベンゼン誘導体(2)に対して1等量以上用いるのが好ましい。 Although there is no restriction | limiting in particular in the usage-amount of acetate, It is preferable to use 1 equivalent or more with respect to a benzene derivative (2) at a point with a sufficient yield.
工程1の反応の反応温度に特に制限は無いが、−100〜200℃の温度から適宜選ばれた温度で反応を実施することができ、収率が良い点で80〜140℃で行うことが望ましい。反応時間に特に制限は無い。 Although there is no restriction | limiting in particular in the reaction temperature of reaction of the process 1, Reaction can be implemented at the temperature chosen suitably from the temperature of -100-200 degreeC, and it is carried out at 80-140 degreeC at a point with a sufficient yield. desirable. There is no particular limitation on the reaction time.
2,2’−ビ(1,3,2−ベンゾジオキサボロール)誘導体(1)の使用量に特に制限は無く、ベンゼン誘導体(2)に対して1等量以上用いることにより収率よく反応は進行する。 There is no restriction | limiting in particular in the usage-amount of a 2,2'-bi (1,3,2- benzodioxaborole) derivative (1), A yield is good by using 1 equivalent or more with respect to a benzene derivative (2). The reaction proceeds.
工程2の反応は、溶媒中で実施することができる。用いることのできる溶媒としては、テトラヒドロフラン、ジエチルエーテル、シクロペンチルメチルエーテル、メチル−tert−ブチルエーテル、1,2−ジメトキシエタン等のエーテル系溶媒、N,N−ジメチルホルムアミド、N−メチルホルムアミド、N−メチルピロリドン、1,3−ジメチル−2−イミダゾリドン等のアミド系溶媒、ジメチルスルホキシド、ジエチルスルホキシド等のスルホキシド系溶媒、メタノール、エタノール、プロパノール、2−プロパノール、エチレングリコール、イソプロピルアルコール、ブタノール、sec−ブチルアルコール、tert−ブチルアルコール、シクロヘキサノール、ヘキサノール、トリフルオロエタノール等のアルコール系溶媒、アセトニトリル、プロピオニトリル等のニトリル系溶媒等の有機溶媒や、水を例示することができる。さらにはこれらの混合溶媒が例示できる。さらに具体的には、ジメチルスルホキシド、N,N−ジメチルホルムアミド、1,2−ジメトキシエタン、エタノール、tert−ブチルアルコール、エタノールとジメチルスルホキシドの混合溶媒、tert−ブチルアルコールとジメチルスルホキシドの混合溶媒、エタノールと水の混合溶媒が好ましい。 The reaction of step 2 can be carried out in a solvent. Solvents that can be used include ether solvents such as tetrahydrofuran, diethyl ether, cyclopentyl methyl ether, methyl-tert-butyl ether, 1,2-dimethoxyethane, N, N-dimethylformamide, N-methylformamide, N-methyl. Amido solvents such as pyrrolidone, 1,3-dimethyl-2-imidazolidone, sulfoxide solvents such as dimethyl sulfoxide, diethyl sulfoxide, methanol, ethanol, propanol, 2-propanol, ethylene glycol, isopropyl alcohol, butanol, sec-butyl alcohol , Alcohol solvents such as tert-butyl alcohol, cyclohexanol, hexanol and trifluoroethanol, and nitrile solvents such as acetonitrile and propionitrile. And organic solvents like, can be exemplified water. Furthermore, these mixed solvents can be illustrated. More specifically, dimethyl sulfoxide, N, N-dimethylformamide, 1,2-dimethoxyethane, ethanol, tert-butyl alcohol, a mixed solvent of ethanol and dimethyl sulfoxide, a mixed solvent of tert-butyl alcohol and dimethyl sulfoxide, ethanol A mixed solvent of water and water is preferred.
利便性の点から、工程1の溶媒をそのまま用いて工程2の反応を行うことが好ましい。溶媒の使用量に特に制限は無い。 From the viewpoint of convenience, it is preferable to carry out the reaction of Step 2 using the solvent of Step 1 as it is. There is no restriction | limiting in particular in the usage-amount of a solvent.
ジオール類(3)の使用量に特に制限は無く、ベンゼン誘導体(2)に対して1等量以上用いることにより収率よく反応は進行する。 There is no restriction | limiting in particular in the usage-amount of diol (3), Reaction progresses with sufficient yield by using 1 equivalent or more with respect to a benzene derivative (2).
工程2の反応の反応温度に特に制限は無いが、−100〜100℃の温度から適宜選ばれた温度で反応を実施することができ、収率が良い点で0〜50℃で行うことが望ましい。反応時間に特に制限は無い。 Although there is no restriction | limiting in particular in the reaction temperature of reaction of the process 2, Reaction can be implemented at the temperature selected suitably from the temperature of -100-100 degreeC, and it can carry out at 0-50 degreeC at a point with a sufficient yield. desirable. There is no particular limitation on the reaction time.
アリール(ジオラート)ボラン類(4)の単離方法に特に制限はなく、溶媒抽出、カラムクロマトグラフィー、分取薄層クロマトグラフィー、分取液体クロマトグラフィー、再結晶、蒸留または昇華等の汎用的な方法で目的物を得ることができる。 There is no particular limitation on the method for isolating aryl (diolate) boranes (4), and general-purpose methods such as solvent extraction, column chromatography, preparative thin layer chromatography, preparative liquid chromatography, recrystallization, distillation or sublimation The object can be obtained by the method.
本発明は、医農薬・電子材料の合成に有用なアリール(ジオラート)ボラン類を簡便な製造方法で得ることができる。 INDUSTRIAL APPLICABILITY According to the present invention, aryl (diolate) boranes useful for the synthesis of medical pesticides and electronic materials can be obtained by a simple production method.
次に本発明を実施例によって詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Next, although an Example demonstrates this invention in detail, this invention is not limited to these.
実施例−1 Example-1
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),3.92(3H,s),7.87(2H,d,J=8.4Hz),8.02(2H,d,J=8.4Hz).
MS(m/z):262[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 3.92 (3H, s), 7.87 (2H, d, J = 8.4 Hz), 8.02 (2H, d, J = 8.4 Hz).
MS (m / z): 262 [M] <+> .
実施例−2
実施例−1のエタノール(6.0mL)に換えて、ジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率56%)。
Example-2
The same operation was performed except that dimethyl sulfoxide (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1, The formation of methyl 3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 56%).
実施例−3
実施例−1のエタノール(6.0mL)に換えて、エタノール(3.0mL)とジメチルスルホキシド(3.0 mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率82%)。
実施例−4
実施例−1のエタノール(6.0mL)に換えて、tert−ブチルアルコール(3.0mL)とジメチルスルホキシド(3.0 mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率46%)。
Example-3
The same operation was performed except that ethanol (3.0 mL) and dimethyl sulfoxide (3.0 mL) were used instead of ethanol (6.0 mL) in Example 1, and 4- (4, 4, 5 , 5-Tetramethyl-1,3,2-dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 82%).
Example-4
The same operation was performed except that tert-butyl alcohol (3.0 mL) and dimethyl sulfoxide (3.0 mL) were used instead of ethanol (6.0 mL) in Example 1, and 4- (4, The formation of methyl 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 46%).
実施例−5
実施例−1の酢酸カリウムを1.0mmol(98mg)とした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率53%)。
Example-5
All the same operations were carried out except that potassium acetate of Example-1 was changed to 1.0 mmol (98 mg), and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl was used. ) Production of methyl benzoate was confirmed by 1 H NMR (NMR yield 53%).
実施例−6
実施例−1の酢酸カリウムを2.00mmol(196mg)とした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率91%)。
Example-6
All the same operations were carried out except that potassium acetate of Example-1 was changed to 2.00 mmol (196 mg), and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl was used. ) Production of methyl benzoate was confirmed by 1 H NMR (NMR yield 91%).
実施例−7
実施例−1の酢酸カリウムを2.50mmol(245mg)とした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-7
All the same operations were performed except that potassium acetate of Example-1 was changed to 2.50 mmol (245 mg), and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl was used. ) Production of methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−8
実施例−1の酢酸カリウムに換えて、酢酸カリウム(1.50mmol,147mg)と酢酸ナトリウム(1.50mmol,123mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率97%)。
Example-8
The same operation was performed except that potassium acetate (1.50 mmol, 147 mg) and sodium acetate (1.50 mmol, 123 mg) were used in place of the potassium acetate of Example-1, and 4- (4, 4, 5 , 5-Tetramethyl-1,3,2-dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 97%).
実施例−9
実施例−1の酢酸カリウムに換えて、酢酸カリウム(0.40mmol,39mg)と酢酸ナトリウム(2.60mmol,213mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率97%)。
Example-9
The same operation was carried out except that potassium acetate (0.40 mmol, 39 mg) and sodium acetate (2.60 mmol, 213 mg) were used in place of the potassium acetate of Example-1, and 4- (4, 4, 5 , 5-Tetramethyl-1,3,2-dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 97%).
実施例−10
実施例−1の酢酸カリウムに換えて、酢酸ナトリウム(3.00mmol,246mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率98%)。
Example-10
The same operation was performed except that sodium acetate (3.00 mmol, 246 mg) was used in place of the potassium acetate of Example-1, and 4- (4,4,5,5-tetramethyl-1,3,3) was used. The formation of methyl 2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 98%).
実施例−11
実施例−1のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、ジクロロビス(アセトニトリル)パラジウム(0.03mmol,8mg)とトリフェニルホスフィン(0.03mmol,8mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率83%)。
Example-11
Instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-1, dichlorobis (acetonitrile) palladium (0.03 mmol, 8 mg) and triphenylphosphine (0.03 mmol, 8 mg) were used. Except for the above, the same operation was carried out, and the formation of methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR Yield 83%).
実施例−12
実施例−1のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、酢酸パラジウム(0.03mmol,7mg)とトリフェニルホスフィン(0.03mmol,8mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率71%)。
Example-12
Except for using dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-1 and using palladium acetate (0.03 mmol, 7 mg) and triphenylphosphine (0.03 mmol, 8 mg). All the same operations were performed, and the formation of methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 71). %).
実施例−13
反応容器に、2,2’−ビ(1,3,2−ベンゾジオキサボロール)(1.10mmol,262mg)、ジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウム(0.030mmol,25mg)、酢酸カリウム(7.20mmol,706mg)を加えてアルゴン置換した。さらにジメチルスルホキシド(6.0mL)を加えた。この反応溶液に4−ブロモ安息香酸メチル(1.00mmol,215mg)を加えて80℃で2時間攪拌した。室温まで冷却後、2,3−ジメチル−2,3−ブタンジオール(2.20mmol,260mg)を加えて、室温でさらに30分攪拌した。反応終了後、反応混合物に水を加え、ヘキサンで抽出した。有機層を無水硫酸マグネシウムで乾燥後、ろ過し、ろ液を濃縮した。得られた残渣を蒸留することにより、白色固体の4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルを得た(252mg,収率96%)。
Example-13
In a reaction vessel, 2,2′-bi (1,3,2-benzodioxaborole) (1.10 mmol, 262 mg), dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium (0. 030 mmol, 25 mg) and potassium acetate (7.20 mmol, 706 mg) were added, and the atmosphere was replaced with argon. Further dimethyl sulfoxide (6.0 mL) was added. To this reaction solution, methyl 4-bromobenzoate (1.00 mmol, 215 mg) was added and stirred at 80 ° C. for 2 hours. After cooling to room temperature, 2,3-dimethyl-2,3-butanediol (2.20 mmol, 260 mg) was added, and the mixture was further stirred at room temperature for 30 minutes. After completion of the reaction, water was added to the reaction mixture and extracted with hexane. The organic layer was dried over anhydrous magnesium sulfate and filtered, and the filtrate was concentrated. The obtained residue was distilled to obtain methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate (252 mg, yield). 96%).
実施例−14
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、ジクロロビス(トリフェニルホスフィン)パラジウム(0.030mmol,21mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-14
The same operation was performed except that dichlorobis (triphenylphosphine) palladium (0.030 mmol, 21 mg) was used instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13. , Methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−15
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、テトラキス(トリフェニルホスフィン)パラジウム(0.030mmol,35mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率97%)。
Example-15
The same operation was carried out except that tetrakis (triphenylphosphine) palladium (0.030 mmol, 35 mg) was used instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13. , 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 97%).
実施例−16
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、塩化パラジウム(0.03mmol,5mg)とトリフェニルホスフィン(0.060mmol,16mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-16
Except for using dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13, palladium chloride (0.03 mmol, 5 mg) and triphenylphosphine (0.060 mmol, 16 mg) were used. All the same operations were performed, and the formation of methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99). %).
実施例−17
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えて、ジクロロビス(アセトニトリル)パラジウム(0.03mmol,5mg)とトリフェニルホスフィン(0.060mmol,16mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率96%)。
Example-17
Instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13, dichlorobis (acetonitrile) palladium (0.03 mmol, 5 mg) and triphenylphosphine (0.060 mmol, 16 mg) were used. Except for the above, the same operation was carried out, and the formation of methyl 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR Yield 96%).
実施例−18
実施例−13のジメチルスルホキシドに換えて、エタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-18
The same procedure was repeated except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolane was used. The formation of methyl-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−19
実施例−13のジメチルスルホキシドに換えて、tert−ブチルアルコール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率64%)。
Example-19
The same operation was performed except that tert-butyl alcohol (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,3) was used. The formation of methyl 2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 64%).
実施例−20
実施例−13のジメチルスルホキシドに換えて、エタノール(3.0mL)とジメチルスルホキシド(3.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-20
The same operation was carried out except that ethanol (3.0 mL) and dimethyl sulfoxide (3.0 mL) were used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl was used. The formation of methyl -1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−21
実施例−13のジメチルスルホキシドに換えて、エタノール(3.0mL)と水(3.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率69%)。
Example-21
The same operation was performed except that ethanol (3.0 mL) and water (3.0 mL) were used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl- The formation of methyl 1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 69%).
実施例−22
実施例−13のジメチルスルホキシドに換えて、tert−ブチルアルコール(3.0mL)とジメチルスルホキシド(3.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率94%)。
Example-22
The same operation was performed except that tert-butyl alcohol (3.0 mL) and dimethyl sulfoxide (3.0 mL) were used instead of dimethyl sulfoxide in Example-13, and 4- (4, 4, 5, 5 -The formation of methyl tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 94%).
実施例−23
実施例−13の酢酸カリウムに換えて、酢酸ナトリウム(7.2mmol,591mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率52%)。
Example-23
The same operation was performed except that sodium acetate (7.2 mmol, 591 mg) was used instead of potassium acetate in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,3) was used. The formation of methyl 2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 52%).
実施例−24
実施例−13の酢酸カリウムに換えて、酢酸カリウム(3.6mmol,353mg)と酢酸ナトリウム(3.6mmol,295mg)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-24
The same operation was performed except that potassium acetate (3.6 mmol, 353 mg) and sodium acetate (3.6 mmol, 295 mg) were used instead of potassium acetate in Example-13, and 4- (4, 4, 5 , 5-Tetramethyl-1,3,2-dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−25 Example-25
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),2.62(3H,s),7.89(2H,d,J=8.4Hz),7.93(2H,d,J=8.4Hz).
MS(m/z):246[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 2.62 (3H, s), 7.89 (2H, d, J = 8.4 Hz), 7.93 (2H, d, J = 8.4 Hz).
MS (m / z): 246 [M] <+> .
実施例−26
実施例−25の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、1−[4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)フェニル]エタノンの生成を1H NMRで確認した(NMR収率91%)。
Example-26
The same operation was performed except that the potassium acetate of Example-25 was 7.2 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 1- [4- (4,4,5 , 5-Tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl] ethanone was confirmed by 1 H NMR (NMR yield 91%).
実施例−27 Example-27
1H−NMR(重クロロホルム,ppm):δ1.34(12H,s),7.34(2H,d,J=8.4Hz),7.73(2H,d,J=8.4Hz).
MS(m/z):239[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.34 (12H, s), 7.34 (2H, d, J = 8.4 Hz), 7.73 (2H, d, J = 8.4 Hz).
MS (m / z): 239 [M] <+> .
実施例−28
実施例−27の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−クロロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率99%)。
Example-28
The same procedure was followed except that the potassium acetate of Example-27 was 7.20 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 2- (4-chlorophenyl) -4,4 , 5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 99%).
実施例−29
実施例−27の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えてN,N−ジメチルホルムアミド(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−クロロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率94%)。
Example-29
The same procedure as in Example 27 was carried out except that the potassium acetate in Example 27 was 7.20 mmol (706 mg) and N, N-dimethylformamide (6.0 mL) was used instead of ethanol. 2- (4-Chlorophenyl) Formation of -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 94%).
実施例−30
実施例−27の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えて1,2−ジメトキシエタン(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−クロロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率37%)。
Example-30
The same procedure was performed except that the potassium acetate of Example-27 was 7.20 mmol (706 mg) and 1,2-dimethoxyethane (6.0 mL) was used instead of ethanol, and 2- (4-chlorophenyl) Formation of -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 37%).
実施例−31 Example-31
1H−NMR(重クロロホルム,ppm):δ1.35(12H,s),7.64(2H,d,J=8.4Hz),7.88(2H,d,J=8.4Hz).
MS(m/z):229[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.35 (12H, s), 7.64 (2H, d, J = 8.4 Hz), 7.88 (2H, d, J = 8.4 Hz).
MS (m / z): 229 [M] <+> .
実施例−32
実施例−31の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンゾニトリルの生成を1H NMRで確認した(NMR収率99%)。
Example-32
The same procedure as in Example 31 was performed except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzonitrile was confirmed by 1 H NMR (NMR yield 99%).
実施例−33 Example-33
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),4.79(1H,s),6.82(2H,d,J=8.6Hz),7.71(2H,d,J=8.6Hz).
MS(m/z):220[M]+。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 4.79 (1H, s), 6.82 (2H, d, J = 8.6 Hz), 7.71 (2H, d, J = 8.6 Hz).
MS (m / z): 220 [M] < + >.
実施例−34
実施例−33の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)フェノールの生成を1H NMRで確認した(NMR収率52%)。
Example-34
The same procedure as in Example 33 was performed except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) phenol was confirmed by 1 H NMR (NMR yield 52%).
実施例−35 Example-35
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),3.83(3H,s),6.89(2H,d,J=8.7Hz),7.75(2H,d,J=8.7Hz).
MS(m/z):234[M]+。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 3.83 (3H, s), 6.89 (2H, d, J = 8.7 Hz), 7.75 (2H, d, J = 8.7 Hz).
MS (m / z): 234 [M] <+> .
実施例−36
実施例−35の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−メトキシフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率98%)。
Example-36
The same procedure as in Example 35 was performed except that potassium acetate in Example 35 was 7.20 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 2- (4-methoxyphenyl) -4, Formation of 4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 98%).
実施例−37 Example-37
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),7.02(2H,d,J=8.5Hz),7.04(3H,t,J=7.5Hz),7.10(4H,d,J=7.8Hz),7.27−7.23(3H,m),7.66(2H,d,J=8.5Hz).
MS(m/z):371[M]+。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 7.02 (2H, d, J = 8.5 Hz), 7.04 (3H, t, J = 7.5 Hz), 7.10 (4H, d, J = 7.8 Hz), 7.27-7.23 (3H, m), 7.66 (2H, d, J = 8.5 Hz).
MS (m / z): 371 [M] <+> .
実施例−38
実施例−37の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、ジフェニル[4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)フェニル]アミンの生成を1H NMRで確認した(NMR収率85%)。
Example-38
The same operation was carried out except that the potassium acetate of Example-37 was adjusted to 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and diphenyl [4- (4, 4, 5, The formation of 5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl] amine was confirmed by 1 H NMR (NMR yield 85%).
実施例−39 Example-39
1H−NMR(重クロロホルム,ppm): δ1.34(12H,s),6.98(2H,d,J=8.6Hz),7.01−7.03(2H,m),7.13(1H,tt,J=1.0,7.4Hz),7.32−7.37(2H,m),7.78(2H,d,J=8.6Hz).
MS(m/z):296[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.34 (12H, s), 6.98 (2H, d, J = 8.6 Hz), 7.01-7.03 (2H, m), 7. 13 (1H, tt, J = 1.0, 7.4 Hz), 7.32-7.37 (2H, m), 7.78 (2H, d, J = 8.6 Hz).
MS (m / z): 296 [M] <+> .
実施例−40
実施例−39の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、フェニル[4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)]フェニル エーテルの生成を1H NMRで確認した(NMR収率65%)。
Example-40
The same operation was carried out except that the potassium acetate of Example-39 was adjusted to 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and phenyl [4- (4, 4, 5, The formation of 5-tetramethyl-1,3,2-dioxaborolan-2-yl)] phenyl ether was confirmed by 1 H NMR (NMR yield 65%).
実施例−41 Example-41
1H−NMR(重クロロホルム,ppm):δ1.34(12H,s),2.32(6H,s),7.10(1H,s),7.44(2H,s).
MS(m/z):232[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.34 (12H, s), 2.32 (6H, s), 7.10 (1H, s), 7.44 (2H, s).
MS (m / z): 232 [M] <+> .
実施例−42
実施例−41の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(3,5−ジメチルフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率99%)。
Example-42
The same procedure was performed except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example-41, and 2- (3,5-dimethylphenyl)- Formation of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 99%).
実施例−43 Example-43
1H−NMR(重クロロホルム,ppm):δ1.32(12H,s),2.98(6H,s),6.68(2H,d,J=8.8Hz),7.67(2H,d,J=8.8Hz).
MS(m/z):247[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.32 (12H, s), 2.98 (6H, s), 6.68 (2H, d, J = 8.8 Hz), 7.67 (2H, d, J = 8.8 Hz).
MS (m / z): 247 [M] <+> .
実施例−44 Example-44
1H−NMR(重クロロホルム,ppm):δ3.93(3H,s),4.41(4H,s),7.88(2H,d,J=8.4Hz),8.04(2H,d,J=8.4Hz).
MS(m/z):206[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 3.93 (3H, s), 4.41 (4H, s), 7.88 (2H, d, J = 8.4 Hz), 8.04 (2H, d, J = 8.4 Hz).
MS (m / z): 206 [M] < + >.
実施例−45
実施例−44の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-45
The same procedure as in Example 44 was conducted except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 4- (1,3,2-dioxaborolane- The formation of 2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−46
反応容器に、2,2’−ビ(1,3,2−ベンゾジオキサボロール)(1.10mmol,262mg)、ジクロロビス(トリフェニルホスフィン)パラジウム(0.030mmol,21mg)、酢酸カリウム(7.20mmol,706mg)を加えてアルゴン置換した。さらにジメチルスルホキシド(6.0mL)を加えた。この反応溶液に4−ブロモ安息香酸メチル(1.00mmol,215mg)を加えて80℃で2時間攪拌した。室温まで冷却後、1,2−エタンジオール(2.20mmol,137mg)を加えて、室温でさらに30分攪拌した。1H NMRにより4−(1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を確認した(NMR収率99%)。
Example-46
In a reaction vessel, 2,2′-bi (1,3,2-benzodioxaborole) (1.10 mmol, 262 mg), dichlorobis (triphenylphosphine) palladium (0.030 mmol, 21 mg), potassium acetate (7 20 mmol, 706 mg) was added, and the atmosphere was replaced with argon. Further dimethyl sulfoxide (6.0 mL) was added. To this reaction solution, methyl 4-bromobenzoate (1.00 mmol, 215 mg) was added and stirred at 80 ° C. for 2 hours. After cooling to room temperature, 1,2-ethanediol (2.20 mmol, 137 mg) was added, and the mixture was further stirred at room temperature for 30 minutes. Formation of methyl 4- (1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−47 Example-47
1H−NMR(重クロロホルム,ppm):δ2.08(2H,quint,J=5.5Hz),3.92(3H,s),4.18(4H,t,J=5.5Hz),7.83(2H,d,J=8.4Hz),8.00(2H,d,J=8.4Hz).
MS(m/z):220[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 2.08 (2H, quint, J = 5.5 Hz), 3.92 (3H, s), 4.18 (4H, t, J = 5.5 Hz), 7.83 (2H, d, J = 8.4 Hz), 8.00 (2H, d, J = 8.4 Hz).
MS (m / z): 220 [M] < + >.
実施例−48
実施例−47のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えてジクロロビス(トリフェニルホスフィン)パラジウム(0.030mmol,21mg)を用いた以外は、全て同じ操作を行い、4−(1,3,2−ジオキサボリナン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-48
The same operation was carried out except that dichlorobis (triphenylphosphine) palladium (0.030 mmol, 21 mg) was used instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-47, Formation of methyl 4- (1,3,2-dioxaborinan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−49
実施例−47の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(1,3,2−ジオキサボリナン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-49
The same procedure was followed except that the potassium acetate of Example-47 was 7.20 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 4- (1,3,2-dioxaborinane- The formation of 2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−50 Example-50
1H−NMR(重クロロホルム,ppm):δ1.03(6H,s),3.79(4H,s),3.92(3H,s),7.86(2H,d,J=8.3Hz),8.00(2H,d,J=8.3Hz).
MS(m/z):248[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.03 (6H, s), 3.79 (4H, s), 3.92 (3H, s), 7.86 (2H, d, J = 8. 3 Hz), 8.00 (2H, d, J = 8.3 Hz).
MS (m / z): 248 [M] <+> .
実施例−51
実施例−50のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムに換えてジクロロビス(トリフェニルホスフィン)パラジウム(0.030mmol,21mg)を用いた以外は、全て同じ操作を行い、4−(5,5−ジメチル−1,3,2−ジオキサボリナン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-51
The same operation was carried out except that dichlorobis (triphenylphosphine) palladium (0.030 mmol, 21 mg) was used instead of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-50, Formation of methyl 4- (5,5-dimethyl-1,3,2-dioxaborinan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−52
実施例−50の酢酸カリウムを7.20mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(5,5−ジメチル−1,3,2−ジオキサボリナン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-52
The same operation was performed except that the potassium acetate of Example-50 was 7.20 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 4- (5,5-dimethyl-1, The formation of methyl 3,2-dioxaborinan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−53 Example-53
1H−NMR(重クロロホルム,ppm):δ1.98(4H,brs),3.92(3H,s),4.22(4H,brs),7.87(2H,d,J=8.4Hz),7.98(2H,d,J=8.4Hz).
MS(m/z):234[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.98 (4H, brs), 3.92 (3H, s), 4.22 (4H, brs), 7.87 (2H, d, J = 8. 4 Hz), 7.98 (2H, d, J = 8.4 Hz).
MS (m / z): 234 [M] <+> .
実施例−54
反応容器に、2,2’−ビ(1,3,2−ベンゾジオキサボロール)(1.10mmol,262mg)、ジクロロビス(トリフェニルホスフィン)パラジウム(0.030mmol,21mg)、酢酸カリウム(7.20mmol,706mg)を加えてアルゴン置換した。さらにジメチルスルホキシド(6.0mL)を加えた。この反応溶液に4−ブロモ安息香酸メチル(1.00mmol,215mg)を加えて80℃で2時間攪拌した。室温まで冷却後、1,4−ブタンジオール(2.20mmol,198mg)を加えて、室温でさらに30分攪拌した。1H NMRにより4−(1,3,2−ジオキサボレパン−2−イル)安息香酸メチルの生成を確認した(NMR収率73%)。
Example-54
In a reaction vessel, 2,2′-bi (1,3,2-benzodioxaborole) (1.10 mmol, 262 mg), dichlorobis (triphenylphosphine) palladium (0.030 mmol, 21 mg), potassium acetate (7 20 mmol, 706 mg) was added, and the atmosphere was replaced with argon. Further dimethyl sulfoxide (6.0 mL) was added. To this reaction solution, methyl 4-bromobenzoate (1.00 mmol, 215 mg) was added and stirred at 80 ° C. for 2 hours. After cooling to room temperature, 1,4-butanediol (2.20 mmol, 198 mg) was added, and the mixture was further stirred at room temperature for 30 minutes. The formation of methyl 4- (1,3,2-dioxabolepan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 73%).
実施例−55
実施例−13の2,2’−ビ(1,3,2−ベンゾジオキサボロール)に換えて、5,5’−ジ−tert−ブチル−2,2’−ビ(1,3,2−ベンゾジオキサボロール)(1.10mmol,385mg)を用いた以外は全て同じ操作を行い、1H NMRにより4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を確認した(NMR収率90%)。
Example-55
Instead of 2,2′-bi (1,3,2-benzodioxaborol) in Example-13, 5,5′-di-tert-butyl-2,2′-bi (1,3, The same operation was performed except that 2-benzodioxaborol) (1.10 mmol, 385 mg) was used, and 4- (4,4,5,5-tetramethyl-1,3,2-) was observed by 1 H NMR. Formation of methyl dioxaborolan-2-yl) benzoate was confirmed (NMR yield 90%).
実施例−56 Example-56
1H−NMR(重クロロホルム,ppm):δ1.32(9H,s),1.33(12H,s),7.40(2H,d,J=8.3Hz),7.75(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ1.32 (9H, s), 1.33 (12H, s), 7.40 (2H, d, J = 8.3 Hz), 7.75 (2H, d, J = 8.3 Hz).
実施例−57
実施例−56の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−tert−ブチルフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率60%)。
Example-57
The same procedure as in Example 56 was performed except that the amount of potassium acetate in Example 56 was 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 2- (4-tert-butylphenyl)- Formation of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 60%).
実施例−58 Example-58
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),1.40(3H,t, J=7.0Hz),4.38(2H,q,J=7.0Hz),7.86(2H,d,J=8.3Hz),8.02(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 1.40 (3H, t, J = 7.0 Hz), 4.38 (2H, q, J = 7.0 Hz), 7.86 (2H, d, J = 8.3 Hz), 8.02 (2H, d, J = 8.3 Hz).
実施例−59
実施例−58の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸エチルの生成を1H NMRで確認した(NMR収率99%)。
Example-59
The same procedure was followed except that the potassium acetate of Example-58 was adjusted to 3.00 mmol (294 mg), and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 4- (4,4,5,5- The production of ethyl tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−60 Example-60
1H−NMR(重クロロホルム,ppm):δ1.34(12H,s),7.20(2H,d,J=8.8Hz),7.84(2H,d,J=8.8Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.34 (12H, s), 7.20 (2H, d, J = 8.8 Hz), 7.84 (2H, d, J = 8.8 Hz).
実施例−61
実施例−60の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−トリフルオロメトキシ[1−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)]ベンゼンの生成を1H NMRで確認した(NMR収率81%)。
Example-61
The same operation was carried out except that the potassium acetate of Example-60 was changed to 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 4-trifluoromethoxy [1- (4, 4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)] benzene was confirmed by 1 H NMR (NMR yield 81%).
実施例−62 Example-62
1H−NMR(重クロロホルム,ppm):δ1.35(12H,s),7.64(2H,d, J=8.3Hz),7.84(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.35 (12H, s), 7.64 (2H, d, J = 8.3 Hz), 7.84 (2H, d, J = 8.3 Hz).
実施例−63
実施例−62の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−トリフルオロメチルチオフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率75%)。
Example-63
The same procedure was followed except that the potassium acetate of Example-62 was changed to 7.2 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 2- (4-trifluoromethylthiophenyl)- Formation of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 75%).
実施例−64 Example-64
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),2.49(3H,s),δ7.22(2H,d,J=8.3Hz),7.70(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 2.49 (3H, s), δ7.22 (2H, d, J = 8.3 Hz), 7.70 (2H, d, J = 8.3 Hz).
実施例−65
実施例−64の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4−メチルチオフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率40%)。
Example-65
The same procedure was performed except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate of Example-64, and 2- (4-methylthiophenyl) -4, Formation of 4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 40%).
実施例−66 Example-66
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),6.79(1H,m),7.13(1H,s),7.17(1H,t,J=7.2Hz),7.21(1H,d,J=7.2Hz)。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 6.79 (1H, m), 7.13 (1H, s), 7.17 (1H, t, J = 7. 2 Hz), 7.21 (1H, d, J = 7.2 Hz).
実施例−67
実施例−66の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)アニリンの生成を1H NMRで確認した(NMR収率85%)。
Example-67
The same procedure was performed except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example-66, and 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) aniline was confirmed by 1 H NMR (NMR yield 85%).
実施例−68 Example-68
1H−NMR(重クロロホルム,ppm):δ1.32(12H,s),3.90(2H,s),6.74(1H,t,J=8.3Hz),7.38(1H,d,J=4.8Hz),7.40(1H,d,J=8.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.32 (12H, s), 3.90 (2H, s), 6.74 (1H, t, J = 8.3 Hz), 7.38 (1H, d, J = 4.8 Hz), 7.40 (1H, d, J = 8.4 Hz).
実施例−69
実施例−68の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−フロオロ−4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)アニリンの生成を1H NMRで確認した(NMR収率60%)。
Example-69
The same operation was carried out except that the potassium acetate of Example-68 was adjusted to 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 2-fluoro-4- (4, 4, The formation of 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) aniline was confirmed by 1 H NMR (NMR yield 60%).
実施例−70 Example-70
1H−NMR(重クロロホルム,ppm):δ1.34(12H,s),2.18(3H,s),2.36(1H,s),7.51(2H,d,J=8.3Hz),7.76(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.34 (12H, s), 2.18 (3H, s), 2.36 (1H, s), 7.51 (2H, d, J = 8. 3 Hz), 7.76 (2H, d, J = 8.3 Hz).
実施例−71
実施例−70の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)アセトアニリドの生成を1H NMRで確認した(NMR収率75%)。
Example-71
The same procedure as in Example 70 was performed except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 4- (4,4,5,5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) acetanilide was confirmed by 1 H NMR (NMR yield 75%).
実施例−72 Example-72
1H−NMR(重クロロホルム,ppm):δ1.35(12H,s),1.68(1H,s),4.72(2H,d,J=5.1Hz),7.37(2H,d,J=7.8Hz),7.81(2H,d,J=8.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.35 (12H, s), 1.68 (1H, s), 4.72 (2H, d, J = 5.1 Hz), 7.37 (2H, d, J = 7.8 Hz), 7.81 (2H, d, J = 8.3 Hz).
実施例−73
実施例−72の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンジルアルコールの生成を1H NMRで確認した(NMR収率76%)。
Example-73
The same procedure was followed except that the potassium acetate of Example-72 was made 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 4- (4,4,5,5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzyl alcohol was confirmed by 1 H NMR (NMR yield 76%).
実施例−74 Example-74
1H−NMR(重クロロホルム,ppm):δ1.35(12H,s),7.80(2H,d,J=7.3Hz),7.88(2H,d,J=7.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.35 (12H, s), 7.80 (2H, d, J = 7.3 Hz), 7.88 (2H, d, J = 7.3 Hz).
実施例−75
実施例−74の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンズアミドの生成を1H NMRで確認した(NMR収率90%)。
Example-75
The same procedure was performed except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example-74, and 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzamide was confirmed by 1 H NMR (NMR yield 90%).
実施例−76 Example-76
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),7.90(2H,d, J=8.3Hz),8.08(2H,d,J=8.3Hz).
IR:1683cm−1。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 7.90 (2H, d, J = 8.3 Hz), 8.08 (2H, d, J = 8.3 Hz).
IR: 1683 cm < -1 >.
実施例−77 Example-77
1H−NMR(重クロロホルム,ppm):δ1.37(12H,s),7.99(3H,d, J=8.3Hz),8.04(2H,d,J=8.3Hz).
19F−NMR(重クロロホルム,ppm):δ−66(1F,s)。
1 H-NMR (deuterated chloroform, ppm): δ 1.37 (12H, s), 7.9 (3H, d, J = 8.3 Hz), 8.04 (2H, d, J = 8.3 Hz).
19 F-NMR (deuterated chloroform, ppm): δ-66 (1F, s).
実施例−78
実施例−77の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンゼンスルホニルフルオリドの生成を1H NMRで確認した(NMR収率20%)。
Example-78
The same procedure was followed except that the potassium acetate of Example-77 was adjusted to 7.2 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 4- (4,4,5,5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzenesulfonyl fluoride was confirmed by 1 H NMR (NMR yield 20%).
実施例−79 Example-79
1H−NMR(重クロロホルム,ppm):δ1.38(12H,s),7.95(2H,d,J=8.5Hz),8.02(2H,d,J=8.6Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.38 (12H, s), 7.95 (2H, d, J = 8.5 Hz), 8.02 (2H, d, J = 8.6 Hz).
実施例−80 Example-80
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),4.75(2H,s),7.91(2H,d,J=8.3Hz),7.95(2H,d,J=8.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 4.75 (2H, s), 7.91 (2H, d, J = 8.3 Hz), 7.95 (2H, d, J = 8.4 Hz).
実施例−81
実施例−80の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンゼンスルホンアミドの生成を1H NMRで確認した(NMR収率45%)。
Example-81
The same operation was performed except that the potassium acetate of Example-80 was 7.2 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, and 4- (4,4,5,5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzenesulfonamide was confirmed by 1 H NMR (NMR yield 45%).
実施例−82 Example-82
1H−NMR(重クロロホルム,ppm):δ1.37(12H,s),7.20−7.24(1H,m),7.33−7.34(2H,m),7.68(1H,d,J=7.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.37 (12H, s), 7.20-7.24 (1H, m), 7.33-7.34 (2H, m), 7.68 ( 1H, d, J = 7.4 Hz).
実施例−83
実施例−82の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(2−クロロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率70%)。
Example-83
The same procedure was performed except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example-82, and 2- (2-chlorophenyl) -4,4 , 5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 70%).
実施例−84 Example-84
1H−NMR(重クロロホルム,ppm):δ1.37(12H,s),7.49−7.51(2H,m),7.65−7.67(1H,m),7.71−7.73(1H,m).
MS(m/z):272[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.37 (12H, s), 7.49-7.51 (2H, m), 7.65-7.67 (1H, m), 7.71- 7.73 (1H, m).
MS (m / z): 272 [M] <+> .
実施例−85
実施例−84の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4,4,5,5−テトラメチル−2−(4−トリフルオロメチルフェニル)−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率50%)。
Example-85
The same operation was carried out except that the potassium acetate of Example-84 was 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 4,4,5,5-tetramethyl- Formation of 2- (4-trifluoromethylphenyl) -1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 50%).
実施例−86 Example-86
1H−NMR(重クロロホルム,ppm):δ1.44(12H,s),2.61(3H,s),7.41−7.45(1H,m),7.51−7.56(2H,m),7.82(2H,d,J=8.6Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.44 (12H, s), 2.61 (3H, s), 7.41-7.45 (1H, m), 7.51-7.56 ( 2H, m), 7.82 (2H, d, J = 8.6 Hz).
実施例−87
実施例−86の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)アセトフェノンの生成を1H NMRで確認した(NMR収率80%)。
Example-87
The same operation was performed except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate of Example-86, and 2- (4,4,5,5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) acetophenone was confirmed by 1 H NMR (NMR yield 80%).
実施例−88 Example-88
1H−NMR(重クロロホルム,ppm):δ1.42(12H,s),3.91(3H,s),7.39−7.43(1H,m),7.49−7.52(2H,m),7.94(1H,d,J=7.6Hz).
MS(m/z):247[M]+。
1 H-NMR (deuterated chloroform, ppm): δ1.42 (12H, s), 3.91 (3H, s), 7.39-7.43 (1H, m), 7.49-7.52 ( 2H, m), 7.94 (1H, d, J = 7.6 Hz).
MS (m / z): 247 [M] <+> .
実施例−89 Example-89
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),2.22(3H,s),2.23(3H,s),2.47(3H,s),6.95(1H,s),7.52(1H,s)。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 2.22 (3H, s), 2.23 (3H, s), 2.47 (3H, s), 6.95 (1H, s), 7.52 (1H, s).
実施例−90
実施例−89の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(2,4,5−トリメチルフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率50%)。
Example-90
The same procedure was performed except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate of Example-89, and 2- (2,4,5-trimethylphenyl) was obtained. ) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 50%).
実施例−91 Example-91
1H−NMR(重クロロホルム,ppm):δ1.38(12H,s),2.39(6H,s),δ6.94(2H,d,J=7.3Hz), 7.12(1H,t,J=7.3Hz).
MS(m/z):232[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.38 (12H, s), 2.39 (6H, s), δ 6.94 (2H, d, J = 7.3 Hz), 7.12 (1H, t, J = 7.3 Hz).
MS (m / z): 232 [M] <+> .
実施例−92
実施例−91の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(2,6−ジメチルフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率30%)。
Example-92
The same procedure as in Example 91 was performed except that 3.00 mmol (294 mg) of potassium acetate was used and ethanol (6.0 mL) was used instead of dimethyl sulfoxide. 2- (2,6-dimethylphenyl)- Formation of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 30%).
実施例−93 Example-93
1H−NMR(重クロロホルム,ppm):δ1.38(12H,s), 7.39−7.42(2H,m), 7.90(1H,t,J=7.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.38 (12H, s), 7.39-7.42 (2H, m), 7.90 (1H, t, J = 7.3 Hz).
実施例−94 Example-94
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),7.38(2H,t, J=7.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.33 (12H, s), 7.38 (2H, t, J = 7.4 Hz).
実施例−95
実施例−94の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、2−(3,4,5−トリフルオロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率99%)。
Example-95
The same procedure as in Example 94 was performed except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 2- (3,4,5-trifluoro Formation of (phenyl) -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 99%).
実施例−96 Example-96
1H−NMR(重クロロホルム,ppm):δ1.33(12H,s),7.14(1H,d, J=10.7Hz),7.52(1H,t,J=6.5Hz),7.58(1H,t,J=9.6Hz)。
1 H-NMR (deuterated chloroform, ppm): δ1.33 (12H, s), 7.14 (1H, d, J = 10.7 Hz), 7.52 (1H, t, J = 6.5 Hz), 7.58 (1H, t, J = 9.6 Hz).
実施例−97
実施例−96の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(3,4−ジフルオロフェニル)−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率80%)。
Example-97
The same procedure was performed except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example-96, and 2- (3,4-difluorophenyl)- Formation of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 80%).
実施例−98 Example-98
1H−NMR(重クロロホルム,ppm):δ1.37(12H,s),7.94(1H,s),8.23(2H,s)。
1 H-NMR (deuterated chloroform, ppm): δ 1.37 (12H, s), 7.94 (1H, s), 8.23 (2H, s).
実施例−99
実施例−98の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、2−[3,5−ビス(トリフルオロメチル)フェニル]−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率99%)。
Example-99
The same procedure as in Example 98 was performed except that 7.2 mmol (706 mg) of potassium acetate was used and dimethyl sulfoxide (6.0 mL) was used instead of ethanol. 2- [3,5-bis (trifluoro) Methyl) phenyl] -4,4,5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 99%).
実施例−100 Example-100
1H−NMR(重クロロホルム,ppm):δ1.32(12H,s),5.95(2H,s),6.83(1H,d,J=7.9Hz),7.24(1H,s), 7.36(1H,d,J=1.1,7.9Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.32 (12H, s), 5.95 (2H, s), 6.83 (1H, d, J = 7.9 Hz), 7.24 (1H, s), 7.36 (1H, d, J = 1.1, 7.9 Hz).
実施例−101
実施例−100の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、5−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)−1,3−ベンゾジオキソールの生成を1H NMRで確認した(NMR収率60%)。
Example-101
The same operation was carried out except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate of Example-100, and 5- (4, 4, 5, 5- Formation of tetramethyl-1,3,2-dioxaborolan-2-yl) -1,3-benzodioxole was confirmed by 1 H NMR (NMR yield 60%).
実施例−102 Example-102
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),7.59(1H,d, J=10.2Hz),7.67(1H,d,J=7.6Hz),7.85(1H,t,J=7.1Hz), 10.40(1H,s).
MS(m/z):250[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 7.59 (1H, d, J = 10.2 Hz), 7.67 (1H, d, J = 7.6 Hz), 7.85 (1H, t, J = 7.1 Hz), 10.40 (1H, s).
MS (m / z): 250 [M] <+> .
実施例−103
実施例−102の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−フルオロ−4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ベンズアルデヒドの生成を1H NMRで確認した(NMR収率60%)。
Example-103
The same procedure was carried out except that the potassium acetate of Example-102 was adjusted to 3.00 mmol (294 mg), and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 2-fluoro-4- (4, 4, The formation of 5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzaldehyde was confirmed by 1 H NMR (NMR yield 60%).
実施例−104 Example-104
実施例−105
実施例−104の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率85%)。
Example-105
The same operation was performed except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example 104, and 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate methyl was confirmed by 1 H NMR (NMR yield 85%).
実施例−106 Example-106
実施例−107
実施例−106の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−メトキシフェニル−2−4,4,5,5−テトラメチル−1,3,2−ジオキサボロランの生成を1H NMRで確認した(NMR収率15%)。
Example-107
The same procedure was carried out except that the potassium acetate of Example-106 was adjusted to 3.00 mmol (294 mg) and ethanol (6.0 mL) was used instead of dimethyl sulfoxide, and 4-methoxyphenyl-2-4,4, Formation of 5,5-tetramethyl-1,3,2-dioxaborolane was confirmed by 1 H NMR (NMR yield 15%).
実施例−108 Example-108
1H−NMR(重クロロホルム,ppm):δ1.01(12H,s),1.90(2H,s),3.75(3H,s),3.92(2H,brs),7.33(2H,d,J=6.8Hz),7.78(2H,d,J=6.8Hz).
MS(m/z):232[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.01 (12H, s), 1.90 (2H, s), 3.75 (3H, s), 3.92 (2H, brs), 7.33 (2H, d, J = 6.8 Hz), 7.78 (2H, d, J = 6.8 Hz).
MS (m / z): 232 [M] <+> .
実施例−109
実施例−108の酢酸カリウムを7.2mmol(706mg)とし、エタノールに換えてジメチルスルホキシド(6.0mL)を用いた以外は、全て同じ操作を行い、4−(5,5−ジメチル−1,3,2−ジオキサボリナン−2−イル)ベンジルアミンの生成を1H NMRで確認した(NMR収率30%)。
Example-109
Except that the potassium acetate of Example-108 was 7.2 mmol (706 mg) and dimethyl sulfoxide (6.0 mL) was used instead of ethanol, the same operation was performed, and 4- (5,5-dimethyl-1, The formation of 3,2-dioxaborinan-2-yl) benzylamine was confirmed by 1 H NMR (NMR yield 30%).
実施例−110 Example-110
1H−NMR(重クロロホルム,ppm):δ1.03(6H,s),3.79(4H,s),2.30(3H,s),6.99(1H,t,J=8.6Hz),7.14−7.19(1H,m),7.50(1H,s).
MS(m/z):222[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.03 (6H, s), 3.79 (4H, s), 2.30 (3H, s), 6.99 (1H, t, J = 8. 6 Hz), 7.14-7.19 (1 H, m), 7.50 (1 H, s).
MS (m / z): 222 [M] < + >.
実施例−111
実施例−110の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、2−(2−フルオロ−5−メチルフェニル)−5,5−ジメチル−1,3,2−ジオキサボリナンの生成を1H NMRで確認した(NMR収率50%)。
Example-111
The same procedure was performed except that ethanol (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate of Example-110, and 2- (2-fluoro-5-methylphenyl) was obtained. ) -5,5-dimethyl-1,3,2-dioxaborinane was confirmed by 1 H NMR (NMR yield 50%).
実施例−112 Example-112
1H−NMR(重クロロホルム,ppm):δ1.06(6H,s),3.78(4H,s),7.44−7.49(2H,m),7.62−7.69(2H,m).
MS(m/z):272[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.06 (6H, s), 3.78 (4H, s), 7.44-7.49 (2H, m), 7.62-7.69 ( 2H, m).
MS (m / z): 272 [M] <+> .
実施例−113 Example-113
1H−NMR(重クロロホルム,ppm):δ1.10 (6H,s),2.38(6H,s),3.79(4H,s), 6.93 (2H,d,J=7.5Hz),7.09(1H,t,J=7.5Hz).
MS(m/z):218[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.10 (6H, s), 2.38 (6H, s), 3.79 (4H, s), 6.93 (2H, d, J = 7. 5 Hz), 7.09 (1H, t, J = 7.5 Hz).
MS (m / z): 218 [M] <+> .
実施例−114 Example-114
1H−NMR(重クロロホルム,ppm):δ1.03(6H,s),1.45(3H,t,J=7.0Hz),3.77(4H,s),4.13(2H,q,J=7.0Hz),6.69(1H,t,J=7.6Hz),7.36(1H,t,J=7.6Hz).
MS(m/z):270[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.03 (6H, s), 1.45 (3H, t, J = 7.0 Hz), 3.77 (4H, s), 4.13 (2H, q, J = 7.0 Hz), 6.69 (1H, t, J = 7.6 Hz), 7.36 (1H, t, J = 7.6 Hz).
MS (m / z): 270 [M] <+> .
実施例−115 Example-115
1H−NMR(重クロロホルム,ppm):δ1.03(6H,s), 3.78(4H,s),7.85(2H,d,J=5.9Hz),8.00(2H,d,J=5.9Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.03 (6H, s), 3.78 (4H, s), 7.85 (2H, d, J = 5.9 Hz), 8.00 (2H, d, J = 5.9 Hz).
実施例−116 Example-116
1H−NMR(重クロロホルム,ppm):δ1.03(6H,s),3.78(4H,s),7.77(2H,d,J=7.7Hz),7.87(2H,d,J=8.2Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.03 (6H, s), 3.78 (4H, s), 7.77 (2H, d, J = 7.7 Hz), 7.87 (2H, d, J = 8.2 Hz).
実施例−117 Example-117
1H−NMR(重クロロホルム,ppm):δ1.11(6H,s),3.80(4H,s),3.92(3H,s),7.36−7.40(1H,m), 7.49−7.52(2H,m), 7.92(1H,t,J=7.3Hz).
MS(m/z):248[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.11 (6H, s), 3.80 (4H, s), 3.92 (3H, s), 7.36-7.40 (1H, m) 7.49-7.52 (2H, m), 7.92 (1H, t, J = 7.3 Hz).
MS (m / z): 248 [M] <+> .
実施例−118 Example-118
1H−NMR(重クロロホルム,ppm):δ1.12(6H,s),2.61(3H,s),3.80(3H,s),7.38−7.42(1H,m),7.52−7.54(2H,m),7.81(1H,d,J=7.7Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.12 (6H, s), 2.61 (3H, s), 3.80 (3H, s), 7.38-7.42 (1H, m) 7.52-7.54 (2H, m), 7.81 (1H, d, J = 7.7 Hz).
実施例−119 Example-119
1H−NMR(重クロロホルム,ppm):δ1.11(6H,s), 1.39(3H,t,J=7.1Hz), 3.79(4H,s), 4.38(2H,q,J=7.1Hz),7.35−7.39(1H,m), 7.49−7.50(2H,m), 7.93(1H,d,J=7.7Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.11 (6H, s), 1.39 (3H, t, J = 7.1 Hz), 3.79 (4H, s), 4.38 (2H, q, J = 7.1 Hz), 7.35-7.39 (1H, m), 7.49-7.50 (2H, m), 7.93 (1H, d, J = 7.7 Hz).
実施例−120 Example-120
1H−NMR(重クロロホルム,ppm):δ1.05(6H,s),3.79(4H,s),7.21(1H,t,J=7.3Hz),7.30−7.34(2H,m), 7.63(1H, d,J=7.3Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.05 (6H, s), 3.79 (4H, s), 7.21 (1H, t, J = 7.3 Hz), 7.30-7. 34 (2H, m), 7.63 (1H, d, J = 7.3 Hz).
実施例−121
実施例−13のジメチルスルホキシドに換えて、トリフルオロエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率18%)。
Example-121
The same operation was carried out except that trifluoroethanol (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,2) was used. The formation of -dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 18%).
実施例−122
実施例−13のジメチルスルホキシドに換えて、1,3−ジメチル−2−イミダゾリドン(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-122
The same procedure was followed except that 1,3-dimethyl-2-imidazolidone (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl was used. The formation of methyl -1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−123
実施例−13のジメチルスルホキシドに換えて、N−メチル−2−ピロリドン(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-123
The same procedure was followed except that N-methyl-2-pyrrolidone (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1 was used. , 3,2-Dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−124
実施例−13のジメチルスルホキシドに換えて、シクロペンチルメチルエーテル(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率42%)。
Example-124
The same operation was carried out except that cyclopentyl methyl ether (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,2) was used. The formation of -dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 42%).
実施例−125
実施例−13のジメチルスルホキシドに換えて、アセトニトリル(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率78%)。
Example-125
The same procedure was followed except that acetonitrile (6.0 mL) was used instead of dimethyl sulfoxide in Example-13, and 4- (4,4,5,5-tetramethyl-1,3,2-dioxaborolane was used. The production of methyl-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 78%).
実施例−126
実施例−1のエタノール(6.0mL)に換えて、プロパノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-126
The same operation was performed except that propanol (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1,3 was used. , 2-Dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−127
実施例−1のエタノール(6.0mL)に換えて、2−プロパノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-127
The same operation was performed except that 2-propanol (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1 was used. , 3,2-Dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−128
実施例−1のエタノール(6.0mL)に換えて、エチレングリコール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率50%)。
Example-128
The same operation was performed except that ethylene glycol (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1, The formation of methyl 3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 50%).
実施例−129
実施例−1のエタノール(6.0mL)に換えて、シクロヘキサノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率86%)。
Example-129
The same operation was performed except that cyclohexanol (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1, The formation of methyl 3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 86%).
実施例−130
実施例−1のエタノール(6.0mL)に換えて、ヘキサノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example-130
The same operation was performed except that hexanol (6.0 mL) was used instead of ethanol (6.0 mL) in Example 1, and 4- (4,4,5,5-tetramethyl-1,3 was used. , 2-Dioxaborolan-2-yl) methyl benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−131
実施例−13の2,3−ジメチル−2,3−ブタンジオールを(1.10mmol,130mg)とした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率91%)。
Example-131
All the same operations were performed except that 2,3-dimethyl-2,3-butanediol of Example-13 was changed to (1.10 mmol, 130 mg), and 4- (4,4,5,5-tetramethyl- The formation of methyl 1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 91%).
実施例−132 Example-132
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),3.92(3H,s),7.87(2H,d,J=8.4Hz),8.02(2H,d,J=8.4Hz).
MS(m/z):262[M]+。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 3.92 (3H, s), 7.87 (2H, d, J = 8.4 Hz), 8.02 (2H, d, J = 8.4 Hz).
MS (m / z): 262 [M] <+> .
実施例−133
実施例−132のエタノール(6.0mL)に換えて、ジメチルスルホキシド(6.0mL)を用い、酢酸カリウム(7.20mmol,706mg)とした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率29%)。
Example-133
The same procedure as in Example 132 was performed except that dimethyl sulfoxide (6.0 mL) was used instead of ethanol (6.0 mL), and potassium acetate (7.20 mmol, 706 mg) was used. The formation of methyl 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 29%).
実施例−134 Example-134
1H−NMR(重クロロホルム,ppm):δ1.40(3H,t,J=7.0Hz),4.38(2H,q,J=7.0Hz),4.41(4H,s),7.88(2H,d,J=8.4Hz),8.04(2H,d,J=8.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.40 (3H, t, J = 7.0 Hz), 4.38 (2H, q, J = 7.0 Hz), 4.41 (4H, s), 7.88 (2H, d, J = 8.4 Hz), 8.04 (2H, d, J = 8.4 Hz).
実施例−135
実施例−134のエタノール(6.0mL)に換えて、ジメチルスルホキシド(6.0mL)を用い、酢酸カリウム(7.20mmol,706mg)とした以外は、全て同じ操作を行い、4−(1,3,2−ジオキサボロラン−2−イル)安息香酸エチルの生成を1H NMRで確認した(NMR収率99%)。
Example-135
The same procedure as in Example 134 was performed except that dimethyl sulfoxide (6.0 mL) was used instead of ethanol (6.0 mL) and potassium acetate (7.20 mmol, 706 mg) was used, and 4- (1, The formation of ethyl 3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−136 Example-136
1H−NMR(重クロロホルム,ppm):δ1.40(3H,t,J=7.0Hz),2.08(2H,quint,J=5.5Hz),4.18(4H,t,J=5.5Hz),4.38(2H,q,J=7.0Hz),7.83(2H,d,J=8.4Hz),8.00(2H,d,J=8.4Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.40 (3H, t, J = 7.0 Hz), 2.08 (2H, quint, J = 5.5 Hz), 4.18 (4H, t, J = 5.5 Hz), 4.38 (2H, q, J = 7.0 Hz), 7.83 (2H, d, J = 8.4 Hz), 8.00 (2H, d, J = 8.4 Hz) .
実施例−137
実施例−136のエタノール(6.0mL)に換えて、ジメチルスルホキシド(6.0mL)を用い、酢酸カリウム(7.20mmol,706mg)とした以外は、全て同じ操作を行い、4−(1,3,2−ジオキサボリナン−2−イル)安息香酸エチルの生成を1H NMRで確認した(NMR収率99%)。
Example-137
The same operation was carried out except that dimethyl sulfoxide (6.0 mL) was used instead of ethanol (6.0 mL) in Example-136, and potassium acetate (7.20 mmol, 706 mg) was used, and 4- (1, Formation of ethyl 3,2-dioxaborinan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例−138 Example-138
1H−NMR(重クロロホルム,ppm):δ1.36(12H,s),7.45(2H,d,J=7.9Hz),7.61(5H, m),7.88(2H,d,J=7.9Hz)。
1 H-NMR (deuterated chloroform, ppm): δ 1.36 (12H, s), 7.45 (2H, d, J = 7.9 Hz), 7.61 (5H, m), 7.88 (2H, d, J = 7.9 Hz).
実施例−139
実施例−138の酢酸カリウムを3.00mmol(294mg)とし、ジメチルスルホキシドに換えてエタノール(6.0mL)を用いた以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)ビフェニルの生成を1H NMRで確認した(NMR収率90%)。
Example-139
The same operation was carried out except that ethanol potassium (6.0 mL) was used instead of dimethyl sulfoxide in an amount of 3.00 mmol (294 mg) of potassium acetate in Example 138, and 4- (4, 4, 5, 5- The formation of tetramethyl-1,3,2-dioxaborolan-2-yl) biphenyl was confirmed by 1 H NMR (NMR yield 90%).
実施例140
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムを0.020mmolとした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example 140
All the same operations were carried out except that 0.020 mmol of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13 was used, and 4- (4,4,5,5-tetramethyl- The formation of methyl 1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
実施例141
実施例−13のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムを0.005mmolとした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率80%)。
Example 141
All the same operations were performed except that 0.005 mmol of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-13 was used, and 4- (4,4,5,5-tetramethyl- The formation of methyl 1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 80%).
実施例142
実施例−1のジクロロ[1,1’−ビス(ジフェニルホスフィノ)フェロセン]パラジウムを0.005mmolとした以外は、全て同じ操作を行い、4−(4,4,5,5−テトラメチル−1,3,2−ジオキサボロラン−2−イル)安息香酸メチルの生成を1H NMRで確認した(NMR収率99%)。
Example 142
All the same operations were performed except that 0.005 mmol of dichloro [1,1′-bis (diphenylphosphino) ferrocene] palladium in Example-1 was used, and 4- (4,4,5,5-tetramethyl- The formation of methyl 1,3,2-dioxaborolan-2-yl) benzoate was confirmed by 1 H NMR (NMR yield 99%).
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011008157A JP5643121B2 (en) | 2010-02-18 | 2011-01-18 | Method for producing aryl (diolato) boranes |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010033994 | 2010-02-18 | ||
| JP2010033994 | 2010-02-18 | ||
| JP2011008157A JP5643121B2 (en) | 2010-02-18 | 2011-01-18 | Method for producing aryl (diolato) boranes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011190240A JP2011190240A (en) | 2011-09-29 |
| JP5643121B2 true JP5643121B2 (en) | 2014-12-17 |
Family
ID=44795533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011008157A Active JP5643121B2 (en) | 2010-02-18 | 2011-01-18 | Method for producing aryl (diolato) boranes |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5643121B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3156946B2 (en) | 1993-04-14 | 2001-04-16 | 株式会社タカトリ | Method and apparatus for sewing pantyhose with a back panel |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104926707B (en) * | 2015-05-12 | 2017-10-27 | 江苏福瑞生物医药有限公司 | A kind of synthetic method of pharmaceutical intermediate |
| JP6616244B2 (en) * | 2015-05-29 | 2019-12-04 | 北興化学工業株式会社 | Novel hydroxyphenylboronic acid ester and method for producing the same, and method for producing hydroxybiphenyl compound |
| CN119219685A (en) * | 2023-06-30 | 2024-12-31 | 浙江大学 | A sugar-responsive molecular connector and its preparation method and application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL154920A0 (en) * | 2000-09-22 | 2003-10-31 | Bayer Cropscience Ag | Delta 1-pyrrollines for use as pesticides |
| FR2871801B1 (en) * | 2004-06-16 | 2006-09-22 | Rhodia Chimie Sa | PROCESS FOR THE PREPARATION OF CYCLIC ARYLBORONATES |
-
2011
- 2011-01-18 JP JP2011008157A patent/JP5643121B2/en active Active
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3156946B2 (en) | 1993-04-14 | 2001-04-16 | 株式会社タカトリ | Method and apparatus for sewing pantyhose with a back panel |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011190240A (en) | 2011-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090005597A1 (en) | Process for Preparing Substituted Biphenyls | |
| KR101915491B1 (en) | Preparation of biaryls | |
| JP5567139B2 (en) | Process for the preparation of aromatic boronic ester compounds | |
| JP5643121B2 (en) | Method for producing aryl (diolato) boranes | |
| ES2308727T5 (en) | METHOD FOR PRODUCING SUBSTITUTED BIFENILOS. | |
| Schnürch et al. | A facile and green synthetic route to boronic acid esters utilizing mechanochemistry | |
| TW201946902A (en) | Method for preparing nitrogen-containing heterocycles | |
| BRPI0911992B1 (en) | PROCESS FOR PREPARING REPLACED BIPHENYLANILIDS | |
| CN110325513B (en) | Method for preparing substituted biphenyl | |
| JPS607608B2 (en) | Production method of acyl cyanide | |
| JP6475524B2 (en) | Method for producing (fluoroalkyl) arene | |
| US8729320B2 (en) | Method for producing difluorocyclopropane compound | |
| Le et al. | Functionalized S-perfluorinated sulfoximines: Preparation and evaluation in catalytic processes | |
| JP6797268B2 (en) | A novel hydroxyphenylboronic acid ester and its production method, and a method for producing a hydroxybiphenyl compound | |
| Brien et al. | Synthesis and characterization of 2, 6-bis-hydrazinopyridine, and its conversion to 2, 6-bis-pyrazolylpyridines | |
| BRPI0806301A2 (en) | process for the preparation of compounds | |
| EP1848678A1 (en) | Process for the preparation of intermediates | |
| JP5770503B2 (en) | Method for producing biphenyls | |
| US7141693B2 (en) | Process for producing β-oxonitrile compound or alkali metal salt thereof | |
| TW486473B (en) | Process for preparing chlorobenzoxazoles | |
| US7238722B2 (en) | Pyrazolylalkines | |
| JP6894608B2 (en) | New Cyclic Urea Derivative-Hydrogen Bromide | |
| US7312350B2 (en) | Process for preparing arylalkynes | |
| Heckel et al. | Crystal structure of 4′-bromo-2, 3, 5, 6-tetrafluorobiphenyl-4-carbonitrile | |
| JPH021412A (en) | Production of phenol derivative containing substituent group at ortho position |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20131220 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20141016 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141028 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141030 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5643121 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |